Ausgabe 9/2014
Inhalt (27 Artikel)
Molecular imaging of misfolded protein pathology for early clues to involvement of the heart
Giampaolo Merlini, Jagat Narula, Eloisa Arbustini
Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography
Sharmila Dorbala, Divya Vangala, James Semer, Christopher Strader, John R. Bruyere Jr, Marcelo F. Di Carli, Stephen C. Moore, Rodney H Falk
Cardiac neuronal imaging with 123I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions
Mario Petretta, Teresa Pellegrino, Alberto Cuocolo
Relationship between quantitative cardiac neuronal imaging with 123I-meta-iodobenzylguanidine and hospitalization in patients with heart failure
Matthew W. Parker, Nitesh Sood, Alan W. Ahlberg, Arnold F. Jacobson, Gary V. Heller, Justin B. Lundbye
A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging
Kenichi Nakajima, Tomoaki Nakata, Takahisa Yamada, Shohei Yamashina, Mitsuru Momose, Shu Kasama, Toshiki Matsui, Shinro Matsuo, Mark I. Travin, Arnold F. Jacobson
Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide
Shu Kasama, Takuji Toyama, Toshiya Iwasaki, Hiroyuki Sumino, Hisao Kumakura, Kazutomo Minami, Shuichi Ichikawa, Naoya Matsumoto, Tomoaki Nakata, Masahiko Kurabayashi
Regional heterogeneity in cardiac sympathetic innervation in acute myocardial infarction: relationship with myocardial oedema on magnetic resonance
Alessia Gimelli, Pier Giorgio Masci, Riccardo Liga, Chrysanthos Grigoratos, Emilio Maria Pasanisi, Massimo Lombardi, Paolo Marzullo
Applicability of the appropriate use criteria for SPECT myocardial perfusion imaging in Italy: preliminary results
G. Medolago, C. Marcassa, A. Alkraisheh, R. Campini, A. Ghilardi, R. Giubbini
Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation
Nobuhiko Joki, Hiroki Hase, Yuhei Kawano, Satoko Nakamura, Kenichi Nakajima, Tsuguru Hatta, Shigeyuki Nishimura, Masao Moroi, Susumu Nakagawa, Tokuo Kasai, Hideo Kusuoka, Yasuchika Takeishi, Mitsuru Momose, Kazuya Takehana, Mamoru Nanasato, Shunichi Yoda, Hidetaka Nishina, Naoya Matsumoto, Tsunehiko Nishimura
In vivo and in vitro evidence that 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery
Andor W. J. M. Glaudemans, Elena Bonanno, Filippo Galli, Clark J. Zeebregts, Erik F. J. de Vries, Michel Koole, Gert Luurtsema, Hendrikus H. Boersma, Maurizio Taurino, Riemer H. J. A. Slart, Alberto Signore
Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis?
Poul F. Høilund-Carlsen, Oke Gerke, Werner Vach
Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma
Ingo Stoffels, Markus Müller, Marie Henrike Geisel, Julia Leyh, Thorsten Pöppel, Dirk Schadendorf, Joachim Klode
Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells
Michel Meignan
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Alexandre Cochet, Olivier Humbert, Michel Toubeau, Emmanuelle Ferrant, François Brunotte, René-Olivier Casasnovas
Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging
Thomas de Perrot, Olivier Rager, Max Scheffler, Martin Lord, Marc Pusztaszeri, Christophe Iselin, Osman Ratib, Jean-Paul Vallee
The value of 18F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors
Benjapa Khiewvan, Homer A. Macapinlac, Dina Lev, Ian E. McCutcheon, John M. Slopis, Ghadah Al Sannaa, Wei Wei, Hubert H. Chuang
Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol
Deepa Rani, Sushma Kaisar, Sushma Awasare, Kamaldeep, Amit Abhyankar, Sandip Basu
Parametric imaging of 18F-fluoro-3-deoxy-3-l-fluorothymidine PET data to investigate tumour heterogeneity
M. Veronese, G. Rizzo, E. O. Aboagye, A. Bertoldo
Preoperative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer
Hyun Hoon Chung, Gi Jeong Cheon, Hee Seung Kim, Jae Weon Kim, Noh-Hyun Park, Yong Sang Song
Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs
Lovisa Nalin, Ram K. Selvaraju, Irina Velikyan, Marie Berglund, Susanne Andréasson, Anna Wikstrand, Anneli Rydén, Mark Lubberink, Fouad Kandeel, Görel Nyman, Olle Korsgren, Olof Eriksson, Marianne Jensen-Waern
Comment on Aksoy et al.: FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection
Elena Lazzeri, Ora Israel, Paola A. Erba, Riddhika Chakravartty, Josè Martin Comin, Francois Jamar, Francois Rouzet, Andor W. J. M. Glaudemans, Alberto Signore
FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection: response to Lazzeri et al
Sabire Yilmaz, Betül Vatankulu, Ozgül Ekmekciogu, Sait Sager, Metin Halac
Comparison of EANM and SNM guidelines on diuretic renography in children
Kathia De Man, Hong Phuoc Duong, Ingeborg Goethals
Michael Riccabona: Pediatric Imaging Essentials—Radiography, Ultrasound, CT, and MRI in Neonates and Children
Manuela Amato, Luigi Mansi
Jean-François H. Geschwind and Michael D. Dake (Eds): Abrams’ Angiography: Interventional Radiology, 3rd edn
Sara M. d. A. Giorgio, Luigi Mansi
Diuretic 18 F-FDG PET/CT for therapy monitoring in urothelial bladder cancer
Elodie Coquan, Charline Lasnon, Florence Joly, Jean-Marc Lefort, Nicolas Aide
Modern radiopharmaceutical solutions and up-to-date technologies, at the 3rd Balkan Congress of Nuclear Medicine
R. Mititelu